80 related articles for article (PubMed ID: 11314780)
1. DNA topoisomerase II-alpha in pulmonary carcinoid tumors.
Resl M; Simek J; Bukac J; Rothröckel P; Siller J
Pathol Res Pract; 2001; 197(3):169-73. PubMed ID: 11314780
[TBL] [Abstract][Full Text] [Related]
2. [Typical and atypical pulmonary carcinoids--pathologic and clinical analysis of 77 cases].
Słodkowska J; Langfort R; Rudziński P; Kupis W
Pneumonol Alergol Pol; 1998; 66(5-6):297-303. PubMed ID: 9857650
[TBL] [Abstract][Full Text] [Related]
3. [Proliferative activity in pulmonary carcinoids].
Resl M; Bukac J; Simek J; Siller J; Rothröckel P
Cesk Patol; 2000 Jan; 36(1):32-4. PubMed ID: 10838756
[TBL] [Abstract][Full Text] [Related]
4. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
[TBL] [Abstract][Full Text] [Related]
5. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
[TBL] [Abstract][Full Text] [Related]
6. Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung.
García-Yuste M; Matilla JM; Cueto A; Paniagua JM; Ramos G; Cañizares MA; Muguruza I;
Eur J Cardiothorac Surg; 2007 Feb; 31(2):192-7. PubMed ID: 17196822
[TBL] [Abstract][Full Text] [Related]
7. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
[TBL] [Abstract][Full Text] [Related]
8. Proliferative activity in primary ovarian carcinoid tumors.
Resl M; Reslová T; Krejcí E; Vagunda V; Nakatani Y; Miyagi E; Bedrna J; Richter P; Vorísek K
Gynecol Endocrinol; 2003 Feb; 17(1):1-6. PubMed ID: 12724012
[TBL] [Abstract][Full Text] [Related]
9. Carcinoid tumor of the lung: clinicopathological study of 32 cases.
Akiba T; Naruke T; Kondo H; Goya T; Tsuchiya R; Suemasu K; Noguchi M; Sakurai K
Jpn J Clin Oncol; 1992 Apr; 22(2):92-5. PubMed ID: 1619783
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical and two-parameter flow cytometric studies of DNA topoisomerase II alpha in human epithelial ovarian carcinoma and germ cell tumor.
Tanoguchi K; Sasano H; Yabuki N; Kikuchi A; Ito K; Sato S; Yajima A
Mod Pathol; 1998 Feb; 11(2):186-93. PubMed ID: 9504690
[TBL] [Abstract][Full Text] [Related]
11. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological features and prognosis of different gastric carcinoid subtypes].
Liang JW; Zhou ZX; Liu Q; Bai XF; Zhao P
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):866-9. PubMed ID: 19173835
[TBL] [Abstract][Full Text] [Related]
13. Primary carcinoid tumor of the middle ear: a potentially metastasizing tumor.
Ferlito A; Devaney KO; Rinaldo A
Acta Otolaryngol; 2006 Mar; 126(3):228-31. PubMed ID: 16618645
[TBL] [Abstract][Full Text] [Related]
14. Lung carcinoids. Tumor angiogenesis in relation to clinicopathologic characteristics.
Slodkowska J; Sikora J; Androsiuk W; Rudziński P; Radomyski A
Anal Quant Cytol Histol; 1999 Jun; 21(3):267-72. PubMed ID: 10560502
[TBL] [Abstract][Full Text] [Related]
15. Interobserver variability for the WHO classification of pulmonary carcinoids.
Swarts DR; van Suylen RJ; den Bakker MA; van Oosterhout MF; Thunnissen FB; Volante M; Dingemans AM; Scheltinga MR; Bootsma GP; Pouwels HM; van den Borne BE; Ramaekers FC; Speel EJ
Am J Surg Pathol; 2014 Oct; 38(10):1429-36. PubMed ID: 25046341
[TBL] [Abstract][Full Text] [Related]
16. Comparison of DNA topoisomerase II alpha expression in small cell and nonsmall cell carcinoma of the lung. In search of a mechanism of chemotherapeutic response.
Guinee DG; Holden JA; Benfield JR; Woodward ML; Przygodzki RM; Fishback NF; Koss MN; Travis WD
Cancer; 1996 Aug; 78(4):729-35. PubMed ID: 8756364
[TBL] [Abstract][Full Text] [Related]
17. The Role of Histologic Grading and Ki-67 Index in Predicting Outcomes in Pulmonary Carcinoid Tumors.
Dermawan JKT; Farver CF
Am J Surg Pathol; 2020 Feb; 44(2):224-231. PubMed ID: 31490236
[TBL] [Abstract][Full Text] [Related]
18. Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.
Stathopoulos GP; Kapranos N; Manolopoulos L; Papadimitriou C; Adamopoulos G
Anticancer Res; 2000; 20(1A):177-82. PubMed ID: 10769652
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects.
Neubauer E; Wirtz RM; Kaemmerer D; Athelogou M; Schmidt L; Sänger J; Lupp A
Oncotarget; 2016 Jul; 7(27):41959-41973. PubMed ID: 27259241
[TBL] [Abstract][Full Text] [Related]
20. [Bronchopulmonary carcinoids: surgical therapy and prognosis].
Huwer H; Kalweit G; Krüger B; Straub U; Schäfers HJ
Pneumologie; 1996 Nov; 50(11):786-9. PubMed ID: 9082447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]